COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

PRIMA US-Feasibility Study in Atrophic Dry AMD (PRIMA-FS-US)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03392324
Recruitment Status : Recruiting
First Posted : January 5, 2018
Last Update Posted : August 21, 2020
Pixium Vision LLC acts as sponosor in the US on behalf of Pixium Vision SA
Information provided by (Responsible Party):
Pixium Vision SA

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2023